Nissan’s new plug-in SUV arrives with a Rogue badge, but anyone who knows the Outlander PHEV will see familiar lines. But instead of engineering a Rogue-based plug-in hybrid, Nissan went for a simpler ...

We have seen the first trailer. We now have a premiere date. Yep, as much as we don't want to admit it, Outlander's final season is barreling toward us. Can you believe the time-travel saga is almost ...

Nov. 10 (UPI) --The final season of romance series Outlander is due March 6, Starz announced on Monday. The series, which premiered in 2014, follows the love story between Claire (Caitriona Balfe) and ...

Starz has set Friday, March 6, as the premiere date for Outlander‘s eighth and final season. New episodes will be available to stream weekly on Fridays via the Starz app and all its streaming and ...

Kimberly-Clark KMB-1.13%decrease; red down pointing triangle has agreed to buy Kenvue KVUE 0.12%increase; green up pointing triangle for more than $40 billion, combining the maker of Huggies diapers ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Consumer giant Kimberly-Clark, which makes Huggies diapers and Kleenex tissues, is buying the company that makes Tylenol and Band-Aids in one of the biggest mergers of the year. The deal, worth almost ...

Kimberly-Clark on Monday said it is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, combining the Huggies manufacturer with the owner of Aveeno and Band-Aid. Kenvue ...

Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion, to create one of the biggest consumer health goods companies in the United ...

Kimberly-Clark (KMB) shares plunged over 15% premarket on Monday after the consumer goods firm entered a deal to acquire all outstanding shares of Tylenol-maker Kenvue (KVUE) in a cash and stock ...

Kimberly-Clark is buying Kenvue, the maker of Tylenol, in a deal worth more than $48 billion, the companies announced on Nov. 3. The deal, which has been approved by each company's board of directors, ...